Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer

被引：0
|
作者：
Xiong, Kai [1 ]
Ding, Shigang [1 ]
机构：
[1] Peking Univ, Dept Gastroenterol, Hosp 3, Beijing, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
histone deacetylase 9; gastric cancer; biomarker;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PD 0007
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [11] HDAC7: a viable target in the treatment of cystic fibrosis
    Franciosi, S.
    CLINICAL GENETICS, 2010, 77 (06)
  • [12] POSTN: a Potential Therapeutic Target in the Treatment of Gastric Cancer?
    Hui-Chuang Yu
    Hong-Mei Guo
    Journal of Gastrointestinal Surgery, 2023, 27 : 1294 - 1294
  • [13] Genetic Variability of Histone Deacetylase 9 (HDAC9) and Treatment Response of Patients with locally advanced Rectal Cancer: Biomarkers for Therapeutic Sensibilities and Implications for Intensification of neoadjuvant Chemoradiotherapy
    Schirmer, M. A.
    Hubert, L.
    Leu, M.
    Hess, C. F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S29 - S29
  • [14] POSTN: a Potential Therapeutic Target in the Treatment of Gastric Cancer?
    Yu, Hui-Chuang
    Guo, Hong-Mei
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (06) : 1294 - 1294
  • [15] Deregulated HDAC9 expression in breast cancer is associated with basal molecular subtype
    Linares, Aurelien
    Lapierre, Marion
    Boulahtouf, Abdel
    Rodriguez, Carmen
    Orsetti, Beatrice
    Balaguer, Patrick
    Maudelonde, Thierry
    Cavailles, Vincent
    Boulle, Nathalie
    CANCER RESEARCH, 2012, 72
  • [16] HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
    Ren, Juan
    Zhang, Jia
    Cai, Hui
    Li, Yi
    Zhang, Yuelang
    Zhang, Xiaozhi
    Zhao, Dongli
    Li, Zongfang
    Ma, Hongbing
    Wang, Jiansheng
    Gao, Yan-e
    Xiao, Lisha
    Liu, Rui
    Qian, Jiansheng
    Liu, Yan
    Wei, Hongxia
    Li, Jinping
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (11) : 1847 - 1856
  • [17] Identification of a new candidate therapeutic target for gastric cancer by in silico analysis
    Kohmoto, Tomohiro
    Masuda, Kiyoshi
    Shoda, Katsutoshi
    Fujita, Yuji
    Tange, Shoichiro
    Ichikawa, Daisuke
    Otsuji, Eigo
    Imoto, Issei
    CANCER RESEARCH, 2018, 78 (13)
  • [18] Identification and validation of Cystatin A as a novel promising therapeutic target for gastric cancer
    Xu, Qingyu
    Xue, Shuai
    Zhang, Yaqiong
    Li, Jian
    Qian, Peiyu
    Zhang, Yanyan
    Feng, Li
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (03) : 873 - 889
  • [19] Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females
    Huang, Yixiang
    Jian, Wei
    Zhao, Junyong
    Wang, Gang
    ONCOTARGETS AND THERAPY, 2018, 11 : 2177 - 2184
  • [20] MicroRNA-383-5p inhibits the progression of gastric carcinoma via targeting HDAC9 expression
    Xu, Gang
    Li, Na
    Zhang, Yan
    Zhang, Jinbiao
    Xu, Rui
    Wu, Yanling
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2019, 52 (08)
12345